UroGen Pharma Ltd. (NASDAQ:URGN) is one of the Stocks With Huge Catalysts on the Horizon. On June 2, UroGen Pharma Ltd.

A different study presented at the 2025 ASCO Annual Meeting showed that one specific diet may benefit people with colon ...

BOSTON--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with ...

Katherine McDaniel, MD, a reproductive endocrinologist, discusses the key takeaways for oncologists treating patients of reproductive age.

Panelists discuss how real-world evidence studies from databases like Flatiron demonstrate that second-generation Bruton ...

OptimTM accurately predicted response in prospective cohort; results published in JCO Precision Oncology, a journal of ASCO SINGAPORE, July 27 ...

July brought major breast cancer updates, and CURE is sharing the latest, as recent developments underscore how quickly the landscape continues to evolve.

A new technology that harnesses artificial intelligence (AI) to analyze mammograms and improve the accuracy of predicting a ...

Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening ...

The biologic and biosimilar era has brought about more clinical trials in rheumatology than ever before, and with increasing ...